EVENT POSTPONED TO 2021

CAR-TCR Summit: To safeguard against COVID-19, we have taken the decision to postpone this event to 2021. Register your interest here to get updated.

Dedicated to the Safe, Clinically Effective and Globally Accessible CAR & TCR Based Cell Therapies in Oncology & Beyond

The 6th CAR-TCR Summit will return to Boston in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.

Bringing together CAR and TCR experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to late-stage commercialization, this is 5 days your team cannot afford to miss!

"An impactful event that is a must-do for anyone working on CAR-TCR therapies."

Bio-Rad
HW190321_CART_Slider_designs4[1] advisroy

2020 Expert Speaker Faculty

Janet Lynch Lambert

CEO

Alliance for Regenerative Medicine

Adrienne Farid

CDO

Century Therapeutics

Peter Marks

Director, CBER

FDA

David Fontana

VP, Cell Therapy Franchise

Juno Therapeutics a Bristol-Myers Squibb Company

Tam Soden

Global Head of Quality Control

Kite, a Gilead Company

Adrian Bot

VP, Translational Medicine

Kite, a Gilead Company

Stefan Hendriks

SVP, Head of Cell & Gene

Novartis

Christina Coughlin

CMO

Rubius Therapeutics

Avery Posey

Assistant Professor, Department of Systems Pharmacology and Translational Therapeutics

University of Pennsylvania

Carl June

Director, Parker Institute for Cancer Immunotherapy

University of Pennsylvania

HW190321_CART_Slider_designs[1] testimonial GE

Lead Partner

Proud to Partner With:

2020 Industry Partners

Other Events in the CAR-TCR Series

As part of the CAR-TCR Series, we are running events in Asia (Shanghai) and in Europe (London). Please visit the individual event pages for more information.

February 24-25, 2021

London

November 2020

Shanghai